Moreover, as the expression level is closely correlated to the overall life span of bladder urothelial carcinoma patients, CDCA3 exhibited the potential to be a novel biomarker of bladder urothelial carcinoma. This evidence concerns the gene CDCA3 and bladder transitional cell carcinoma.